Bangladesh signs MoU with Indian Company for collecting 3 crores Coronavirus vaccine

▴ Bangladesh signs MoU with Indian Company for collecting 3 crores Coronavirus vaccine
An MoU was signed on 5th Nov between the government of Bangladesh, Beximco Pharmaceutical Ltd and the Serum Institute of India for priority delivery of 3 crores COVID-19 vaccine doses.

The process of development of the vaccine is in the final stages at the University of Oxford and AstraZeneca.

Health Minister of Bangladesh Zahid Maleque and High Commissioner of India to Bangladesh Vikram Doraiswami were present on the occasion along with other senior officials of the Health Ministry of Bangladesh and the two companies.

Calling it a ‘landmark agreement’, Health Minister Zahid Maleque expressed the hope that the people of Bangladesh will get relief from this. He said that initially 1.5 crore people will be vaccinated as each person will require two doses of the vaccine.

High Commissioner Vikram Doraiswami said that the vaccine from India was chosen not only because it was the best price but also because it is most suitable for the conditions for the distribution of the vaccine in Bangladesh.

He said that the vaccine is also one of the most promising candidates which are being brought up to the international regulators. The High Commissioner said that it is the culmination of the agenda that Prime Minister Narendra Modi put forward in March this year when he told SAARC leaders that this battle should be fought together and won together.

Meanwhile, new air service between India and Bangladesh under the air-bubble arrangement started yesterday. Welcoming the start of the new service, Bangladesh State Minister for Civil Aviation Md. Mahbub Ali said that the air-bubble arrangement between the two countries has helped people who need to travel for medical, business, and other purposes. He pointed out that Bangladesh and India enjoyed excellent relations and Prime Minister Sheikh Hasina is working to further strengthen people to people ties between the two countries.

Tags : #Bangladesh #India #AstraZeneca #UniversityofOxford #PMNarendraModi #PMSeikhHasina #COVIDvaccine #LatestPharmaNews6thNov

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Cipla Eyes Eli Lilly Partnership to Tap Growing Demand for Obesity Drugs in IndiaMay 13, 2024
Setback for Organ Transplantion: First Human to Receive Pig Kidney DiesMay 13, 2024
Why AstraZeneca is Withdrawing the Covid-19 Vaccine Globally: Explained May 13, 2024
Achieving Healthier Lifestyles: Understanding India's New Dietary GuidelinesMay 11, 2024
The Link Between Childhood Sleep and Adult Psychosis: A Critical AnalysisMay 11, 2024
Uncovering Immunization Gaps: Insights into Measles Vaccination Challenges in IndiaMay 11, 2024
Unlocking New Horizons: Gene Therapies for Hearing Loss and BlindnessMay 10, 2024
Kerala Health Alert: West Nile Fever Cases Confirmed in Thrissur, Malappuram, and KozhikodeMay 10, 2024
Managing Health in the Heat: Demand for Medications Surges in IndiaMay 10, 2024
Sudhamukti Ayurvedic Medicine by OJSP: A New Era in Diabetes ManagementMay 10, 2024
The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
Reducing Stigma, One Story at a Time: Media's Role in Mental HealthMay 07, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024